the chart does not indicate sell off on horizon .. .. What metrics are you looking at? .. fundamentals pointing stock overvalued?
agreed. Consolidation for a few weeks would be good for this stock. however, you never know about stocks. You may wait for a pull back and never get it until it hits $5 ... Or you may buy in now and get stuck
Disagree. Chart is overbought on any measure and needs a pull back to $1.5 and consolidation for a few weeks at least.
However, the outlook is driving shares higher despite being overbought.
CEO said gap profitability by end of fourth (by end of June). This can happen only with both improving top line and gross margins. This may or may not happen, but it does show their anticipated top line and bottom line growth in a short amount of time. I do not believe they were counting on any additional big wins with this outlook. If that happens it would be a big plus.
Warrants being exercised would bring more buying pressure, as the company cash position will improve which is a big plus for winning other big projects and further validate major investor confidence in this stock.
My view is that this is a stock that you will look back in December 2014 and you would say, wish I had bought at $1.8 ...
for mos of the day. Buying, waitnig to price drop back, then buy again.
Out of 1 million shares, my guess is that 700,000 share was bought by one or more investors.
$7 by end of June is my guess. Could happen earlier if they announce a big win (similar size to VA) prior to that.
Their CC talked about Dept of Defense (DOD) mimicking VA.
A reasonable speculation. But, it is only spec at this point. CEO said starting next month this will happen
Lowering manufacturing cost is good and results in better gross margins. Also, adds a dual source supply in the mean time. Use of offshore offshore to meet higher expected volume is a speculation, but a reasonable one.
ADAT is at stage 1 of a 10 stage ramp up.
Info on warrants and converts is all in 10k
For the sake of talking to myself, since no one here seems to bother .. As i listened to the presentation (and bo that is a long call), somewhere in the middle, CEO said gross margins on products are now around 20%. He then said they are moving a manufacturing offshore bringing gross margins up to 60% on products (someone please double check)...
So, their confidence must in large part come from lower manufacturring cost. Say, $2M revenue and getting gross margins from 25% to 60% is an extra $900,000 ... Reduction will not get to all revenue but you get the idea
Also, CEO said margins on recurring revenue is above 85%. I guess, as they sell these products, the high margin revenue should follow shortly afterwards
For whatever it is worth, I listened to yesterdays presentation (could not see slides) and CEO said starting next month, they expect to bring down the cost of devices by a lot .. So, am just guessing they expect better gross margins on products sold in Q2 and after. He did not say by how? You guys have any guess?
Also, he talked about recurring revenue in general terms
Appreciate feedback from those who follow company closely
3rd quarter ..
Does this have to do with expectation of recurring revenue for what they have so far sold?
From last CC, they were burning $275,000 a month. Their system makes about $50 a month and I imagine is a high margin. So, do they see signing up about 5,000 patients on their network by the 3rd quarter? Is this where they get the confidence?
Bought today based on the following observations:
1- Trend is to lower cost, so trend is in favor of ADAT
2- VA is in very early stages of ramping up. Want to get 600,000 patients in the next 3 years. Maybe too ambitious, but even if meet a fraction is huge
3- Recurring revenue model
4- Appears (at least to me) that they have best of breed technology
5- CEO says pipeline for others like VA is big. Some will go to ADAT.
6- Warrant and converts will add around $35M cash and total shares to use for market cap is 70 million
7- In such high growth environment, ADAT will get a p/e of 35 once profitable. To achieve a $7 share price, it needs $3.5M quarterly income which can be reached fairly quickly (given they have already guided cash break even in a few months and proftiable shortly after that.
My short term target (6 months) is $7
LOL ... you are doing oposite .. FUD to but low .. They have been buying stock every quarter and are now EBITDA positive ex Rutgin ...
Bought it because tape looked good. I have a graduate degree in Electrical Engineering. Not really a good day trader and probably not a good stock picker. But I am an excellent engineer / problem solver.
So, went to OTIV company presentation and then read about Patent US 6,045,043.
The patent is so basic that I really don't see how could anyone not violate this patent and use NFC.
So, I am guessing the main reason stock going well is this patent. Thoughts ??
why would you sell, when major investors bought $919,000 at $3.4
April is less than 5 months away. Stock could be up to $10 before then in anticipation of Avastin + Zyberstat P2 results
There are good recent lit indicating combretastatin-A4 phosphate is very effective in tumor growth stop.
Again, I can only think of tax loss selling for someone selling so cheap. By en of this year, OXGN still will have over $7M cash, no debt and lots of patents and a drug that helps with cancer outcome.
if you are right, then it is priced at $3 .. you and me can not get that price .. if you can, buy all you can
they will raise about $20M and have $5M on hand .. so, $25M cash and 20 million share outstanding so, at $3 is a $60M company with $25M cash ... very cheap
NOW, BUY the gap down tomorrow.
After secondary, it will have $25M cash, no debt and low market cap. CHEAP !!